| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469, 2018 | 2411 | 2018 |
| Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer Cell 31 (6), 737-754. e6, 2017 | 1103 | 2017 |
| Comprehensive analysis of hypermutation in human cancer BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ... Cell 171 (5), 1042-1056. e10, 2017 | 727 | 2017 |
| Epigenomic alterations define lethal CIMP-positive ependymomas of infancy SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ... Nature 506 (7489), 445, 2014 | 653 | 2014 |
| Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ... Nature genetics 46 (5), 451, 2014 | 644 | 2014 |
| Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ... Cancer cell 29 (3), 379-393, 2016 | 542 | 2016 |
| Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers A Shlien, BB Campbell, R de Borja, LB Alexandrov, D Merico, D Wedge, ... Nature genetics 47 (3), 257, 2015 | 388 | 2015 |
| Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor α and poly (ADP-ribose) polymerase as potential … M Zarghooni, U Bartels, E Lee, P Buczkowicz, A Morrison, A Huang, ... Journal of clinical oncology 28 (8), 1337-1344, 2010 | 361 | 2010 |
| Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ... Journal of clinical oncology: official journal of the American Society of …, 2017 | 322 | 2017 |
| BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma M Mistry, N Zhukova, D Merico, P Rakopoulos, R Krishnatry, M Shago, ... Journal of clinical oncology 33 (9), 1015, 2015 | 298 | 2015 |
| Frequent amplification of a chr19q13. 41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors M Li, KF Lee, Y Lu, I Clarke, D Shih, C Eberhart, VP Collins, T Van Meter, ... Cancer cell 16 (6), 533-546, 2009 | 279 | 2009 |
| Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016 | 239 | 2016 |
| Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological … A Korshunov, D Sturm, M Ryzhova, V Hovestadt, M Gessi, DTW Jones, ... Acta neuropathologica 128 (2), 279-289, 2014 | 236 | 2014 |
| Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience L Lafay-Cousin, C Hawkins, AS Carret, D Johnston, S Zelcer, B Wilson, ... European journal of cancer 48 (3), 353-359, 2012 | 225 | 2012 |
| Phase II weekly vinblastine for chemotherapy-naive children with progressive low-grade glioma: a Canadian Pediatric Brain Tumor Consortium Study A Lassaletta, K Scheinemann, SM Zelcer, J Hukin, BA Wilson, N Jabado, ... Journal of Clinical Oncology 34 (29), 3537-3543, 2016 | 224 | 2016 |
| Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR CL Kleinman, N Gerges, S Papillon-Cavanagh, P Sin-Chan, ... Nature genetics 46 (1), 39, 2014 | 218 | 2014 |
| Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ... Nature 553 (7686), 101, 2018 | 203 | 2018 |
| TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ... Acta neuropathologica 126 (6), 917-929, 2013 | 199 | 2013 |
| KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers TW Corson, A Huang, MS Tsao, BL Gallie Oncogene 24 (30), 4741, 2005 | 193 | 2005 |
| Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor A Huang, CE Campbell, L Bonetta, MS McAndrews-Hill, ... Science 250 (4983), 991-994, 1990 | 190 | 1990 |
